Have a personal or library account? Click to login
Acute Coronary Syndrome Following Long-Term Erlotinib Treatment Cover

Acute Coronary Syndrome Following Long-Term Erlotinib Treatment

Internal Medicine
Volume 15 (2018): Issue 3 (July 2018)
By: Traian Constantin Panciu,  Bianca Masgras,  Catrinel Ciuca,  Raluca Ciomag,  Anca Mihăilescu and  Adriana Gurghean  
Open Access
|Jul 2018

References

  1. 1. Orphanos GS1, Ioannidis GN, Ardavanis AG. Cardiotoxicity induced by tyrosine kinase inhibitors. Acta Oncol. 2009; 48(7):964-70.10.1080/02841860903229124
    Open DOISearch in Google ScholarBack to article
  2. 2. Ming Hui Chen, Risto Kerkelä, Thomas Force. Mechanisms of Cardiac Dysfunction Associated With Tyrosine Kinase Inhibitor Cancer Therapeutics. Circulation. 2008;118:84-9510.1161/CIRCULATIONAHA.108.776831
    Open DOISearch in Google ScholarBack to article
  3. 3. SHANSHAN DING, FEI LONG, and SHUJUAN JIANG. Acute myocardial infarction following erlotinib treatment for NSCLC: A case report. Oncol Lett. 2016 Jun; 11(6): 4240–424410.3892/ol.2016.4508
    Search in Google ScholarBack to article
  4. 4. Tulay Kus, Gokmen Aktas, Alper Sevinc, Mehmet Emin Kalender, and Celaletdin Camci. Could erlotinib treatment lead to acute cardiovascular events in patients with lung adenocarcinoma after chemotherapy failure?.Onco Targets Ther. 2015; 8: 1341–1343.10.2147/OTT.S84480
    Search in Google ScholarBack to article
  5. 5. Merimsky O1, Cheng CK, Au JS, von Pawel J, Reck M. Efficacy and safety of first-line erlotinib in elderly patients with advanced non-small cell lung cancer. Oncol Rep. 2012 Aug;28(2):721-7.10.3892/or.2012.1824
    Open DOISearch in Google ScholarBack to article
DOI: https://doi.org/10.2478/inmed-2018-0023 | Journal eISSN: 1220-5818 | Journal ISSN: 1220-5818
Journal RSS Feed
Language: English
Page range: 61 - 66
Published on: Jul 20, 2018
Published by: Romanian Society of Internal Medicine
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Erlotinib,
tyrosine kinase inhibitor,
non-small cell lung cancer,
acute coronary syndrome
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Internal medicine, other,
Cardiology,
Gastroenterology,
Pneumology

© 2018 Traian Constantin Panciu, Bianca Masgras, Catrinel Ciuca, Raluca Ciomag, Anca Mihăilescu, Adriana Gurghean, published by Romanian Society of Internal Medicine
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 15 (2018): Issue 3 (July 2018)Next article